Sudair Pharmaceutical Company
Bader Alkutaili is a PharmD with extensive experience in regulatory affairs and quality control within the pharmaceutical industry. Currently serving as an International Regulatory Affairs Specialist at Sudair Pharmaceutical Company since December 2021, Bader previously held the role of Regulatory Affairs Specialist and was engaged in quality control and regulatory affairs at Alqefary Medical Group from January 2021 to November 2021. Responsibilities included managing regulatory relationships, preparing documentation, and maintaining up-to-date knowledge of regulations. Earlier roles comprised quality control officer tasks, including oversight of corrective action plans and assisting with FDA inspections. Bader completed a PharmD at Qassim University from 2013 to 2020 and gained research experience as a student researcher at King Abdullah International Medical Research Center in 2018.
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.